Novavax, Inc.

GAITHERSBURG, Md., 2017-02-20 22:05 CET (GLOBE NEWSWIRE) --

Novavax, Inc. (Nasdaq:NVAX) today announced it will report its fourth quarter and full year 2016 financial and operating results following the close of U.S. financial markets on Monday, February 27, 2017.

Conference call details are as follows:

Date:		Monday, February 27, 2017
Time:		4:30 p.m. U.S. Eastern Time (ET)
Dial-in number:		(877) 212-6076 (Domestic) or (707) 287-9331 (International)
Passcode:		61206704
Webcast:		www.novavax.com, “Investors”/ “Events”

Conference call and webcast replay:

Dates:		Starting at 7:30 p.m. ET, February 27, 2017, until midnight March 3, 2017
Dial-in number:		(855) 859-2056 (Domestic) or (404) 537-3406 (International)
Passcode:		61206704
Webcast:		www.novavax.com, “Investors”/ “Events”, until April 30, 2017

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Its recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines.

Contact:

Investor Relations
Novavax, Inc.
Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations
ir@novavax.com
240-268-2000

Westwicke Partners
John Woolford
john.woolford@westwicke.com
443-213-0506

Media
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull@russopartnersllc.com
212-845-4271